Bath & Body Works (NYSE:BBWI) Updates Q2 2025 Earnings Guidance

Bath & Body Works (NYSE:BBWI) updated its second quarter 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.330-0.380 for the period, compared to the consensus estimate of 0.420. The company issued revenue guidance of -, compared to the consensus revenue estimate of $1.6 billion.

Bath & Body Works Stock Down 6.2%

Shares of Bath & Body Works stock opened at $28.58 on Friday. Bath & Body Works has a 12-month low of $24.96 and a 12-month high of $52.99. The firm has a market capitalization of $6.09 billion, a PE ratio of 6.97, a price-to-earnings-growth ratio of 0.92 and a beta of 1.87. The stock’s fifty day moving average is $30.15 and its 200-day moving average is $33.96.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.47 by $0.02. The firm had revenue of $1.40 billion for the quarter, compared to analysts’ expectations of $1.42 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. Bath & Body Works’s revenue was up 2.9% on a year-over-year basis. During the same quarter last year, the business posted $0.38 EPS. Analysts expect that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.80%. The ex-dividend date is Friday, June 6th. Bath & Body Works’s dividend payout ratio (DPR) is currently 21.98%.

Bath & Body Works announced that its board has initiated a share buyback plan on Thursday, February 27th that permits the company to buyback $500.00 million in outstanding shares. This buyback authorization permits the company to reacquire up to 6.4% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.

Analysts Set New Price Targets

A number of research firms recently commented on BBWI. Wells Fargo & Company raised their price objective on shares of Bath & Body Works from $40.00 to $44.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 14th. Piper Sandler set a $39.00 target price on Bath & Body Works and gave the company an “overweight” rating in a report on Thursday, May 15th. Barclays lifted their price target on Bath & Body Works from $31.00 to $35.00 and gave the company an “equal weight” rating in a report on Tuesday, May 20th. The Goldman Sachs Group reduced their price objective on Bath & Body Works from $49.00 to $42.00 and set a “buy” rating for the company in a research note on Tuesday, April 22nd. Finally, Morgan Stanley decreased their price objective on Bath & Body Works from $49.00 to $43.00 and set an “overweight” rating for the company in a research report on Tuesday, May 6th. Four equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Bath & Body Works presently has a consensus rating of “Moderate Buy” and a consensus price target of $42.25.

Institutional Investors Weigh In On Bath & Body Works

Large investors have recently made changes to their positions in the company. Geneos Wealth Management Inc. lifted its stake in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares during the last quarter. Intech Investment Management LLC bought a new position in shares of Bath & Body Works during the 1st quarter valued at $1,155,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Bath & Body Works by 7.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock valued at $17,063,000 after purchasing an additional 36,684 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of Bath & Body Works by 15.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock valued at $19,586,000 after purchasing an additional 87,529 shares during the last quarter. Finally, Royal Bank of Canada boosted its holdings in Bath & Body Works by 92.8% in the first quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock worth $1,815,000 after purchasing an additional 28,815 shares in the last quarter. Institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.